Literature DB >> 19100378

Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation.

J S Ko1, G S Kim, M S Gwak, M Yang, H K Kim, B S Shin, J K Kim, S K Lee.   

Abstract

OBJECTIVE: University of Wisconsin (UW) and histidine-tryptophan-ketoglutarate (HTK) solutions are the 2 most commonly used liver preservation solutions. The aim of this study was to compare cardiovascular stability, acid-base status, and potassium concentrations between patients who received grafts preserved in either UW or HTK solution in orthotopic liver transplantation (OLT). PATIENTS AND METHODS: In this retrospective study, 87 patients who underwent living donor OLT were divided into 2 groups: UW (n = 28) and HTK (n = 59). Group HTK was subdivided into group NF-HTK (n = 31; nonflushed before reperfusion) and group F-HTK (n = 28; flushed before reperfusion). We determined mean arterial pressure (MAP) and heart rate every minute for 5 minutes after reperfusion and the maximum change in these values and incidence of postreperfusion syndrome (PRS). Body temperature, cardiovascular and acid-base parameters, as well as potassium concentrations were compared at 5 minutes before and 5 and 30 minutes after reperfusion.
RESULTS: The maximum decreases in MAP within 5 minutes after reperfusion were significantly greater in both the NF-HTK and the F-HTK groups. The rate of PRS was significantly greater in the NF-HTK compared with the UW group. Flushing with HTK solution decreased the rate of PRS; there was no significant difference between the F-HTK and UW groups. All serial changes in body temperature, cardiovascular and acid-base parameters, as well as potassium concentrations were similar among the 3 groups.
CONCLUSIONS: The incidence of PRS was greater using HTK compared with UW solution during the reperfusion period. Therefore, careful hemodynamic management is advised when using HTK solution.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100378     DOI: 10.1016/j.transproceed.2008.04.022

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

Review 1.  Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies.

Authors:  Antonio Siniscalchi; Lorenzo Gamberini; Cristiana Laici; Tommaso Bardi; Giorgio Ercolani; Laura Lorenzini; Stefano Faenza
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

2.  Histidine-tryptophan-ketoglutarate and University of Wisconsin solution demonstrate equal effectiveness in the preservation of human pancreata intended for islet isolation: a large-scale, single-center experience.

Authors:  Daniel H Paushter; Meirigeng Qi; Kirstie K Danielson; Tricia A Harvat; Katie Kinzer; Barbara Barbaro; Sonny Patel; Sarah Z Hassan; Jose Oberholzer; Yong Wang
Journal:  Cell Transplant       Date:  2012-10-02       Impact factor: 4.064

3.  Impact of Graft Weight Change During Perfusion on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation.

Authors:  Jong Man Kim; Young Jae Chung; Sangjin Kim; Jinsoo Rhu; Gyu-Seong Choi; Jae-Won Joh
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

4.  Post-reperfusion syndrome during renal transplantation: a retrospective study.

Authors:  Steven R Bruhl; Sandeep Vetteth; Michael Rees; Blair P Grubb; Samer J Khouri
Journal:  Int J Med Sci       Date:  2012-07-16       Impact factor: 3.738

5.  Arrhythmogenic potential develops rapidly at graft reperfusion before the start of hypotension during living-donor liver transplantation.

Authors:  Hwa-Mi Lee; Soo-Kyoung Park; Young-Jin Moon; Jung-Won Kim; Sun-Key Kim; Bo-Hyun Sang; Dong-Kyun Seo; Byoung-Woo Yoo; Gyu-Sam Hwang
Journal:  Korean J Anesthesiol       Date:  2016-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.